BMT Program Meetings
Held every Monday
|09/08/14||Angiogenic factors in GVHD: Lessons from pregnancy||Dr. Shernan Holtan|
|09/15/14||BMT Protocol Updates|
|09/22/14||Proteomic studies in idiopathic pneumonia syndrome||Maneesh Bhargava|
|09/29/14||Update on ID Studies||JoAnne Young|
|10/06/14||Single cell analyses to understand mechanisms of AML self-renewal||Zohar Sachs, M.D., Ph.D.|
|10/13/14||Hemorrhagic cystitis: What does our experience demonstrate?||Celalettin Ushun, M.D.|
|10/20/14||Mitochondrial polymorphism and outcomes following HCT||Julie Ross, Ph.D.|
|10/27/14||Clinical consequences of early chimerism in UCB transplantation||Nelli Bejanyan, M.D.|
|11/03/14||Physician Utilization Reviews (Karyn Baum) - 30 minutes |
GVHD Disease Forms (Judy Witte) - 20 minutes
Donor consent - 10 minutes
|Karyn Baum and Judy Witte|
|11/10/14||9th Annual Children's Cancer Research Fund Norma K.C. Ramsay, M.D. Distinguished Visiting Professor Lectureshi |
Regulatory T cells and the quest for transplant tolerance
|Dr. Maria-Grazia Roncarolo |
Host: John Wagner, M.D.
|11/17.14||Genoptypic and immunophenotypic signatures of drug resistance in multiple myeloma||Michael Linden, M.D., Ph.D., Assistant Professor, Laboratory Medicine and Pathology |
Brian Van Ness, Ph.D., Professor, Genetics, Cell Biology and Development
|11/24/14||ASH Practice Talks|
|12/01/14||ASH Practice Talks|
|12/08/14||Cancelled due to ASH annual meeting|
|01/05/15||B cell receptor signatures from mRNA-seq predict outcome in basal-like breast cancer||Benjamin Vincent, M.D., Fellow, University of North Carolina Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center |
Faculty candidate, HOT Division
|01/12/15||Veronika Bachanova, M.D., Ph.D.|
|01/19;15||No conference due to Martin Luther King holiday|
|01/26/15||Vaccine approaches to control cytomegalovirus infection in stem cell transplant recipients and to prevent in utero congenital infection||Don Diamond, Ph.D. |
Chair and Professor, Department of Experimental Therapeutics
City of Hope
Host: Jeffrey Miller, M.D.
|02/16/15||Cancelled : Tandem|
Alex Lazaryan, M.D.
|03/02/15||Brian McClune, D.O.|
|03/30/15||Characterizing and Targeting Ras Signaling in AML||Craig Eckfeldt, M.D., Ph.D.|
|04/06/15||VIP Cancer Immunotherapy||Edmund Waller, M.D., Ph.D. |
Professor of Medicine, Pathology and Hematology/Oncology
Emory School of Medicine
Associate Director for Clinical Research
Winship Cancer Institute
Host: Jeffrey Miller, M.D.
Defining perfect immune reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT)
Kidney transplant after hematopoietic stem cell transplant: Infections, complications, and immunosuppressive considerations
Mayada Abu Shanap, M.D.
Christen Ebens, M.D.
|04/27/15||BMT for metachromatic leukodystrophy||Weston Miller, M.D.|
|05/04/15||Developing new cellular therapies to treat GVHD following stem cell transplantation||Keli Hippen,Ph.D.|
|05/18/15||Erica Warlick, M.D.|
|05/25/15||Cancelled: Memorial Day Holiday|